Contrast advanced dynamic flow imaging and contrast pulse subtraction imaging: Preliminary results in hepatic tumors

Journal of Medical Ultrasonics

Volumn 29, Issue WINTER, 2002, Pages 195-204

  Wen, Yan Ling ^a,b   Kudo, Masatoshi ^a   Maekawa, Kiyoshi ^a   Minami, Yasunori ^a   Chung, Hobyung ^a   Suetomi, Yoichiro ^a   Onda, Hirokazu ^a   Kitano, Masayuki ^a   Kawasaki, Toshihiko ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Contrast media; Liver neoplasm; Pulse inversion harmonic imaging; Ultrasound; Wide band harmonic imaging

Indexed keywords

CONTRAST MEDIUM; SHU 508;

ADENOMA; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ADVANCED DYNAMIC FLOW IMAGING; CONTRAST PULSE SUBTRACTION IMAGING; DOPPLER FLOWMETRY; HEMANGIOMA; HEMODYNAMICS; IMAGE SUBTRACTION; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPH NODE METASTASIS; METASTASIS; REAL TIME ECHOGRAPHY; VASCULARIZATION;

EID: 0036959609     PISSN: 13441388     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02480850     Document Type: Article

References (25)

1. Leen B, McArdle CS: Ultrasound contrast agent in liver imaging. Clin Radiol 1996; 51 (suppl): 35-39.
2. Maresca G, Summaria V, Colagrande C, et al: New prospects for ultrsound contrast agents. Eur J Radiol 1998; 27: s171-s178.
3. Calliada F, Campani R, Bottinelli O, et al: Ultrasound contrast agents: basic principles. Eur J Radiol 1998; 27: s157-s160.
4. Cosgrove D: Ultrasound contrast enhancement of tumors. Clin Radiol 1996; 51 (suppl): 44-49.
5. Burns PN: Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996; 51 (suppl): 50-55.
6. Fujimoto M, Moriyasu F, Nishikawa K, et al: Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR Am J Roentgenol 1994; 163: 1099-1104.
7. Tanaka S, Kitamra T, Yoshioka F, et al: Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol 1995; 21: 157-160.
8. Kim AY, Choi BI, Kim TK, et al: Hepatocellular carcinoma: power Doppler US with a contrast agent-preliminary results. Radiology 1998; 209: 135-140.
9. Forsberg F, Liu JB, Burns PN, et al: Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994; 13: 357-365.
10. Choi BI, Kim TK, Han JK, et al: Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 2000; 214: 381-386.
11. Ding H, Kudo M, Onda H, et al: Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001; 220: 349-356.
12. Numata K, Tanaka K, Kiba T, et al: Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings. J Ultrasound Med 2001; 20: 89-98.
13. Wilson SR, Burns PN, Muradali D, et al: Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000; 215: 153-161.
14. Jang HJ, Lim HK, Lee WJ, et al: Ultrasonographic evaluation of focal hepatic lesions: comparison of pulse inversion harmonic, tissue harmonic, and conventional imaging techniques. J Ultrasound Med 2000; 19: 293-299.
15. Burns PN, Wilson SR, Simpson DH: Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35: 58-71.
16. Kim TK, Choi BI, Han JK, et al: Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000; 216: 411-417.
17. Albrecht T, Hoffmann CW, Schmitz SA, et al: Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver matastases. AJR Am J Roentgenol 2001; 176: 1191-1198.
18. Ding H, Kudo M, Onda H, et al: Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocelluar carcinoma. AJR Am J Roentgenol 2001; 176: 661-666.
19. Tanaka S, Kitamura T, Fujita M, et al: Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990; 154: 509-514.
20. Kawasaki T, Itani T, Nakase H, et al: Power Doppler imaging of hepatic tumors: differential diagnosis between hepatocellular carcinoma and metastatic adenocarcinoma. J Gastroenterol Hepatol 1998; 13: 1152-1160.
21. Kudo M: Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. Hepatogastroenterology 1998; 45: 1226-1231.
22. Kudo M: Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19: 297-309.
23. Kudo M, Tomita S, Tochio H, et al: Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. AJR Am J Roentgenol 1992; 158: 65-74.
24. Kamiyama N, Moriyasu F, Mine Y, et al: Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol 1999; 25: 411-420.
25. Kamiyama N, Moriyasu F, Kono Y, et al: Investigation of the "flash echo" signal associated with a US contrast agent. Radiology 1996; 201 (p): 158.